| Community-associated infection | Healthcare-associated infection |
---|---|---|
n | n | |
Carbapenem-resistant Acinetobacter baumannii | 8 (16%) | 42 (84%) |
Carbapenem-resistant Pseudomonas aeruginosa | 7 (21%) | 26 (79%) |
Multidrug-resistant Pseudomonas aeruginosa | 11 (34%) | 21 (66%) |
Carbapenem-resistant Enterobacteriaceae | 10 (43%) | 13 (56%) |
Enterobacteriaceae, ESBL-producing | 148 (45%) | 181 (55%) |
Methicillin-resistant Staphylococcus aureus (MRSA) | 12 (35%) | 22 (65%) |
Erythromycin-resistant group A streptococcus | 5 (71%) | 2 (29%) |